Insulin therapy for adult patients with type 2 diabetes mellitus

A position statement of the Korean diabetes association, 2017

on behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association

Research output: Contribution to journalReview articleResearchpeer-review

1 Citation (Scopus)

Abstract

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

Original languageEnglish
Pages (from-to)367-373
Number of pages7
JournalDiabetes and Metabolism Journal
Volume41
Issue number5
DOIs
StatePublished - 1 Oct 2017

Fingerprint

Type 2 Diabetes Mellitus
Insulin
Clinical Trials
Therapeutics
Practice Guidelines
Hypoglycemic Agents
Physicians
Safety

Keywords

  • Clinical practice guideline
  • Diabetes mellitus
  • Hypoglycemic agents
  • Insulin
  • Korea
  • Type 2

Cite this

on behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association. / Insulin therapy for adult patients with type 2 diabetes mellitus : A position statement of the Korean diabetes association, 2017. In: Diabetes and Metabolism Journal. 2017 ; Vol. 41, No. 5. pp. 367-373.
@article{6f1f3a783a9b4486a4c79be5680bfc68,
title = "Insulin therapy for adult patients with type 2 diabetes mellitus: A position statement of the Korean diabetes association, 2017",
abstract = "The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.",
keywords = "Clinical practice guideline, Diabetes mellitus, Hypoglycemic agents, Insulin, Korea, Type 2",
author = "{on behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association} and Lee, {Byung Wan} and Kim, {Jin Hwa} and Ko, {Seung Hyun} and Hur, {Kyu Yeon} and Kim, {Nan Hee} and Rhee, {Sang Youl} and Kim, {Hyun Jin} and Moon, {Min Kyong} and Park, {Seok O.} and Choi, {Kyung Mook} and Kim, {Tae Nyun} and Lee, {Yong Ho} and Kim, {Jin Hwa} and Hong, {Eun Gyoung} and Jaetaek Kim and Lee, {Won Young} and Bokrye Song and Kim, {Ji Young} and Yang, {Dong Hee} and {Taeyoung Yang}, Yang and {Hyeongjin Kim}, Kim",
year = "2017",
month = "10",
day = "1",
doi = "10.4093/dmj.2017.41.5.367",
language = "English",
volume = "41",
pages = "367--373",
journal = "Diabetes and Metabolism Journal",
issn = "2233-6079",
publisher = "Korean Diabetes Association",
number = "5",

}

Insulin therapy for adult patients with type 2 diabetes mellitus : A position statement of the Korean diabetes association, 2017. / on behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association.

In: Diabetes and Metabolism Journal, Vol. 41, No. 5, 01.10.2017, p. 367-373.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Insulin therapy for adult patients with type 2 diabetes mellitus

T2 - A position statement of the Korean diabetes association, 2017

AU - on behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association

AU - Lee, Byung Wan

AU - Kim, Jin Hwa

AU - Ko, Seung Hyun

AU - Hur, Kyu Yeon

AU - Kim, Nan Hee

AU - Rhee, Sang Youl

AU - Kim, Hyun Jin

AU - Moon, Min Kyong

AU - Park, Seok O.

AU - Choi, Kyung Mook

AU - Kim, Tae Nyun

AU - Lee, Yong Ho

AU - Kim, Jin Hwa

AU - Hong, Eun Gyoung

AU - Kim, Jaetaek

AU - Lee, Won Young

AU - Song, Bokrye

AU - Kim, Ji Young

AU - Yang, Dong Hee

AU - Taeyoung Yang, Yang

AU - Hyeongjin Kim, Kim

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

AB - The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

KW - Clinical practice guideline

KW - Diabetes mellitus

KW - Hypoglycemic agents

KW - Insulin

KW - Korea

KW - Type 2

UR - http://www.scopus.com/inward/record.url?scp=85032590852&partnerID=8YFLogxK

U2 - 10.4093/dmj.2017.41.5.367

DO - 10.4093/dmj.2017.41.5.367

M3 - Review article

VL - 41

SP - 367

EP - 373

JO - Diabetes and Metabolism Journal

JF - Diabetes and Metabolism Journal

SN - 2233-6079

IS - 5

ER -